Fidelity Investments’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298M | Buy |
|
|||||
|
2025
Q1 | $294M | Buy |
|
|||||
|
2024
Q4 | $484M | Sell |
|
|||||
|
2024
Q3 | $254M | Buy |
|
|||||
|
2024
Q2 | $277M | Buy |
|
|||||
|
2024
Q1 | $251M | Buy |
|
|||||
|
2023
Q4 | $238M | Buy |
|
|||||
|
2023
Q3 | $258M | Buy |
|
|||||
|
2023
Q2 | $661M | Buy |
|
|||||
|
2023
Q1 | $951M | Buy |
|
|||||
|
2022
Q4 | $1.15B | Buy |
|
|||||
|
2022
Q3 | $1.17B | Buy |
|
|||||
|
2022
Q2 | $872M | Buy |
|
|||||
|
2022
Q1 | $889M | Buy |
|
|||||
|
2021
Q4 | $586M | Sell |
|
|||||
|
2021
Q3 | $961M | Sell |
|
|||||
|
2021
Q2 | $2.13B | Buy |
|
|||||
|
2021
Q1 | $1.2B | Sell |
|
|||||
|
2020
Q4 | $1.67B | Sell |
|
|||||
|
2020
Q3 | $1.11B | Sell |
|
|||||
|
2020
Q2 | $619M | Sell |
|
|||||
|
2020
Q1 | $797M | Sell |
|
|||||
|
2019
Q4 | $1.03B | Buy |
|
|||||
|
2019
Q3 | $890M | Buy |
|
|||||
|
2019
Q2 | $651M | Sell |
|
|||||
|
2019
Q1 | $503M | Sell |
|
|||||
|
2018
Q4 | $375M | Buy |
|
|||||
|
2018
Q3 | $568M | Buy |
|
|||||
|
2018
Q2 | $246M | Buy |
|
|||||
|
2018
Q1 | $152M | Sell |
|
|||||
|
2017
Q4 | $163M | Buy |
|
|||||
|
2017
Q3 | $155M | Buy |
|
|||||
|
2017
Q2 | $119M | Buy |
|
|||||
|
2017
Q1 | $37.1M | Sell |
|
|||||
|
2016
Q4 | $38.4M | Buy |
|
|||||
|
2016
Q3 | $41.7M | Sell |
|
|||||
|
2016
Q2 | $58.3M | Sell |
|
|||||
|
2016
Q1 | $80M | Buy |
|
|||||
|
2015
Q4 | $116M | Buy |
|